89bio ETNB 深 沪
等待开盘 08-06 09:30:00 美东时间
9.69
+0.350
+3.75%
华盛通- 最 高9.79
- 今 开9.39
- 成交量 202.91万股
- 最 低 9.14
- 昨 收 9.34
- 总市值 14.15亿
- 52周最高 11.84
- 市盈率 静 --
- 换手率 1.39%
- 52周最低 4.16
- 委 比 -24.43%
- 总股本 1.46亿
- 历史最高 47.253
- 量 比 1.50
- 振 幅 6.96%
- 历史最低 2.00
- 每 手 1
- 风险率 1.33%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多新浪财经ESG：ETNB MSCI（明晟）ESG评级调降至A
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务，助力上市公司传播ESG理念，提升ESG可持续发展表现。点击查看【 ESG评级中...
06-19 07:00
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
89bio, a clinical-stage biopharmaceutical company focused on treating liver and cardiometabolic diseases, announced the grant of non-qualified stock options to purchase 61,100 shares of its common stock to three new employees under its 2023 Inducement Plan. The options, granted on June 3, 2025, have an exercise price equal to the closing price of the company's stock on the grant date. They vest over four years, with 25% vesting after the first ye...
06-06 20:05
89bio to Participate in Goldman Sachs 46th Annual Global Healthcare Conference
89bio, a clinical-stage biopharmaceutical company focused on therapies for liver and cardiometabolic diseases, announced that its management will participate in a fireside chat at the Goldman Sachs 46th Annual Global Healthcare Conference on June 11, 2025, and hold one-on-one investor meetings. The event will be available via webcast on 89bio’s website, with replays accessible for 30 days. The company is advancing its lead candidate, pegozafermin...
06-04 20:05
Why Vertiv Holdings Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
Shares of Vertiv Holdings Co (NYSE:VRT) rose sharply in today's pre-market trad...
04-23 19:01
89bio Updates on Pegozafermin Clinical Progress
89bio ( ($ETNB) ) has shared an announcement. On April 9, 2025, 89bio released ...
04-09 22:48
美股大行评级 | Tigress Financial：维持爱彼迎"买入"评级，目标价从195美元升至200美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1107588488073326592.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持ProQR Therapeutics(PRQR)"买入"评级，目标价从10美元升至12美元</p> <p>• Oppenheimer：上调内克塔治疗(NKTR)评级至"跑
03-17 10:10
89bio (ETNB) Receives a New Rating from Goldman Sachs
89bio (ETNB – Research Report) received a Hold rating and an $11.00 price targe...
03-14 14:35
美股大行评级 | 花旗：首予BioNTech SE(BNTX)"买入"评级，目标价145美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1107226114384474112.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Canaccord Genuity：维持Zevra Therapeutics(ZVRA)"买入"评级，目标价从23美元升至25美元</p> <p>• Benchmark：维持E W Scripps(SSP)"买入"评级，目
03-14 09:45
快讯 | 89bio Inc : 花旗集团首次覆盖，给予买入评级；目标价25美元
89Bio Inc : Citigroup Initiates Coverage With Buy Rating; Price Target $25
03-13 18:30
89bio to Participate in the Leerink Partners Global Healthcare Conference
SAN FRANCISCO, March 03, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the "Company" or...
03-04 05:05
